TipRanks
Go Ultimate55% OFF

Avalo Therapeutics (AVTX) Balance Sheet

Avalo Therapeutics Balance Sheet

Avalo Therapeutics's total assets for Q2 2026 were $490.78M, an increase of 391.35% from the previous quarter. AVTX total liabilities were $42.12M for the fiscal quarter, a 33.45% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 116.46M$ 150.73M$ 20.99M$ 33.37M$ 80.21M
$ 33.41M$ 17.70M$ 13.69M$ 44.28M$ 57.13M
$ 83.05M$ 133.03M$ 7.30M$ -10.91M$ 23.08M

Currency in USD

Avalo Therapeutics Debt to Assets

060M120M180M0 %50 %100 %150 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets